October 27, 1997Archives of Internal Medicine
Duration of Anticoagulant Therapy After First Episode of Venous Thrombosis in Patients With Inherited Thrombophilia
Why the study?
What is the optimal duration of anticoagulant therapy to prevent VTE recurrence in patients with inherited thrombophilia?
Population
Patients with acute venous thrombosis or pulmonary embolism (VTE) and inherited/familial thrombophilia
Design
Other
Authors
Discussion
Loading...
Member takes
Implication
Risk-benefit balancing guides duration decisions in inherited thrombophilia; leaves open precise thresholds pending higher-level evidence.
Key Points
- To evaluate the optimal duration of anticoagulant therapy following an initial episode of venous thromboembolism in patients with inherited thrombophilia by balancing recurrence risks against bleeding complications.
- Evaluated the risk-benefit profile of standard 3-to-6-month anticoagulant regimens compared to prolonged therapy following acute venous thrombosis or pulmonary embolism.
- Assessed recurrence patterns and bleeding probabilities specifically in high-risk patient subsets with familial or inherited thrombophilia.
- Anticoagulant therapy effectively manages acute venous thromboembolism, but treatment continuation entails an ongoing risk of bleeding.
- Recurrence rates decline over time after an acute event, but patients with inherited thrombophilia face persistently elevated recurrence risks after completing 3 to 6 months of anticoagulation.
Structured PICO
What is the optimal duration of anticoagulant therapy to prevent VTE recurrence in patients with inherited thrombophilia?
P
Population
Patients with acute venous thrombosis or pulmonary embolism (VTE) and inherited/familial thrombophilia
I
Intervention
Anticoagulant therapy
O
Outcome
Recurrence of venous thromboembolism
The optimal duration of anticoagulant therapy in patients with inherited thrombophilia requires balancing the risk of VTE recurrence against the risk of bleeding.
Cite This Study
Jack Hirsh (1997) studied this question.